BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-Arranz M, Herreros MD, González-Gómez C, de la Quintana P, Guadalajara H, Georgiev-Hristov T, Trébol J, Garcia-Olmo D. Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial. Stem Cells Transl Med 2016;5:1441-6. [PMID: 27412883 DOI: 10.5966/sctm.2015-0356] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 13.6] [Reference Citation Analysis]
Number Citing Articles
1 Guadalajara Labajo H, León Arellano M, Vaquero Crespo J, Valverde Núñez I, García-Olmo D. Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following stem cell therapy. J Surg Case Rep 2018;2018:rjy300. [PMID: 30443317 DOI: 10.1093/jscr/rjy300] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Norderval S, Lundby L, Hougaard H, Buntzen S, Weum S, de Weerd L. Efficacy of autologous fat graft injection in the treatment of anovaginal fistulas. Tech Coloproctol. 2018;22:45-51. [PMID: 29285682 DOI: 10.1007/s10151-017-1739-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
3 López-Beas J, Guadix JA, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient. Med Res Rev 2020;40:1315-34. [PMID: 32017179 DOI: 10.1002/med.21659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Abu Gazala M, Wexner SD. Management of rectovaginal fistulas and patient outcome. Expert Rev Gastroenterol Hepatol 2017;11:461-71. [PMID: 28276809 DOI: 10.1080/17474124.2017.1296355] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
5 Lightner AL. A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine. Inflamm Bowel Dis 2018;24:1689-94. [PMID: 29788100 DOI: 10.1093/ibd/izy084] [Reference Citation Analysis]
6 Castro-poceiro J, Fernández-clotet A, Panés J. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease. Immunotherapy 2018;10:1203-17. [DOI: 10.2217/imt-2018-0099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Wang S, Zhu R, Li H, Li J, Han Q, Zhao RC. Mesenchymal stem cells and immune disorders: from basic science to clinical transition. Front Med. 2018;. [PMID: 30062557 DOI: 10.1007/s11684-018-0627-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
8 Bernardi L, Santos CHMD, Pinheiro VAZ, Oliveira RJ, Antoniolli-Silva ACMB. TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN'S DISEASE: SYSTEMATIC REVIEW. Arq Bras Cir Dig 2019;32:e1465. [PMID: 31859918 DOI: 10.1590/0102-672020190001e1465] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ma WT, Gao F, Gu K, Chen DK. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review. Front Immunol 2019;10:1140. [PMID: 31178867 DOI: 10.3389/fimmu.2019.01140] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 30.5] [Reference Citation Analysis]
10 Spinelli A, Armuzzi A, Ciccocioppo R, Danese S, Gionchetti P, Luglio G, Orlando A, Rispo A, Rizzello F, Sofo L, Solina G, Poggioli G. Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality. Digestive and Liver Disease 2020;52:506-15. [DOI: 10.1016/j.dld.2019.11.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wainstein C, Quera R, Fluxá D, Kronberg U, Conejero A, López-Köstner F, Jofre C, Zarate AJ. Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up. Colorectal Dis 2018. [PMID: 29316139 DOI: 10.1111/codi.14002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
12 Ciccocioppo R, Fioravante M, Frulloni L. Mesenchymal stromal cell therapy in intestinal diseases. Curr Opin Organ Transplant 2018;23:679-89. [PMID: 30300331 DOI: 10.1097/MOT.0000000000000586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Buscail E, Le Cosquer G, Gross F, Lebrin M, Bugarel L, Deraison C, Vergnolle N, Bournet B, Gilletta C, Buscail L. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn's Disease: Rationale, Clinical Results and Perspectives. Int J Mol Sci 2021;22:9967. [PMID: 34576129 DOI: 10.3390/ijms22189967] [Reference Citation Analysis]
14 Sutermaster BA, Darling EM. Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting. Sci Rep 2019;9:227. [PMID: 30659223 DOI: 10.1038/s41598-018-36698-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
15 Choi S, Jeon BG, Chae G, Lee SJ. The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol 2019;23:411-27. [PMID: 31049792 DOI: 10.1007/s10151-019-01994-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
16 Gui C, Parson J, Meyer GA. Harnessing adipose stem cell diversity in regenerative medicine. APL Bioeng 2021;5:021501. [PMID: 33834153 DOI: 10.1063/5.0038101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG, Clark SK, Clifford S, Davies RJ, Davies MM, Douie WJP, Dunlop MG, Epstein JC, Evans MD, George BD, Guy RJ, Hargest R, Hawthorne AB, Hill J, Hughes GW, Limdi JK, Maxwell-Armstrong CA, O'Connell PR, Pinkney TD, Pipe J, Sagar PM, Singh B, Soop M, Terry H, Torkington J, Verjee A, Walsh CJ, Warusavitarne JH, Williams AB, Williams GL, Wilson RG; ACPGBI IBD Surgery Consensus Collaboration. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis. 2018;20 Suppl 8:3-117. [PMID: 30508274 DOI: 10.1111/codi.14448] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 13.5] [Reference Citation Analysis]
18 Ko JZ, Johnson S, Dave M. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.Biomolecules. 2021;11. [PMID: 33440772 DOI: 10.3390/biom11010082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Millán-Rivero JE, Nadal-Nicolás FM, García-Bernal D, Sobrado-Calvo P, Blanquer M, Moraleda JM, Vidal-Sanz M, Agudo-Barriuso M. Human Wharton's jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors. Sci Rep 2018;8:16299. [PMID: 30389962 DOI: 10.1038/s41598-018-34527-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
20 DeLeon MF, Hull TL. Treatment Strategies in Crohn's-Associated Rectovaginal Fistula. Clin Colon Rectal Surg. 2019;32:261-267. [PMID: 31275072 DOI: 10.1055/s-0039-1683908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
21 Ciccocioppo R, Dos Santos CC, Baumgart DC, Cangemi GC, Cardinale V, Ciacci C, De Coppi P, Haldar D, Klersy C, Nostro MC, Ott M, Piemonti L, Tomei AA, Uygun B, Vetrano S, Orlando G. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. Cytotherapy 2018;20:461-76. [PMID: 29398624 DOI: 10.1016/j.jcyt.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
22 Rios Rodriguez V, Llop M, Poddubnyy D. Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? Immunotherapy 2017;9:899-911. [PMID: 29338611 DOI: 10.2217/imt-2017-0034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, Sørensen JA. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Transl Med 2017;6:1786-94. [PMID: 28722289 DOI: 10.1002/sctm.17-0031] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 17.8] [Reference Citation Analysis]
24 Sebbagh AC, Rosenbaum B, Péré G, Alric H, Berger A, Wilhelm C, Gazeau F, Mathieu N, Rahmi G, Silva AKA. Regenerative medicine for digestive fistulae therapy: Benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021;:113841. [PMID: 34175308 DOI: 10.1016/j.addr.2021.113841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Sarnik SA, Sutermaster BA, Darling EM. Mass-Added Density Modulation for Sorting Cells Based on Differential Surface Protein Levels. Cytometry A 2021;99:488-95. [PMID: 32687243 DOI: 10.1002/cyto.a.24192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Guevara-Martínez J, Barragán C, Bonastre J, Zarbakhsh S, Cantero R. Rectoneovaginal fistula after sex reassignment surgery. Description of our experience and literature review. Actas Urol Esp (Engl Ed) 2021;45:239-44. [PMID: 33139068 DOI: 10.1016/j.acuro.2020.08.012] [Reference Citation Analysis]
27 McDermott FD. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease, by Nikolic et al. Colorectal Dis 2021;23:4. [PMID: 33501776 DOI: 10.1111/codi.15508] [Reference Citation Analysis]
28 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
29 Lightner AL, Dozois EJ, Dietz AB, Fletcher JG, Friton J, Butler G, Faubion WA. Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas. Inflamm Bowel Dis 2020;26:670-7. [PMID: 31605115 DOI: 10.1093/ibd/izz215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
30 Naldini G, Sturiale A, Fabiani B, Giani I, Menconi C. Micro-fragmented adipose tissue injection for the treatment of complex anal fistula: a pilot study accessing safety and feasibility. Tech Coloproctol 2018;22:107-13. [PMID: 29453515 DOI: 10.1007/s10151-018-1755-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
31 Turse EP, Dailey FE, Naseer M, Partyka EK, Tahan V. One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy. World J Clin Cases 2018; 6(12): 493-500 [PMID: 30397605 DOI: 10.12998/wjcc.v6.i12.493] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Draganov DD, Santidrian AF, Minev I, Nguyen D, Kilinc MO, Petrov I, Vyalkova A, Lander E, Berman M, Minev B, Szalay AA. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med 2019;17:100. [PMID: 30917829 DOI: 10.1186/s12967-019-1829-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
33 Nikolic M, Stift A, Reinisch W, Vogelsang H, Matic A, Müller C, von Strauss Und Torney M, Riss S. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease. Colorectal Dis 2021;23:153-8. [PMID: 32810356 DOI: 10.1111/codi.15324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. Stem Cells Int 2020;2020:7819824. [PMID: 32256612 DOI: 10.1155/2020/7819824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
35 Trébol J, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Stem cell therapy for faecal incontinence: Current state and future perspectives. World J Stem Cells 2018; 10(7): 82-105 [PMID: 30079130 DOI: 10.4252/wjsc.v10.i7.82] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Molendijk I, van der Meulen-de Jong AE, Verspaget HW, Veenendaal RA, Hommes DW, Bonsing BA, Peeters KCMJ. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease. Eur J Gastroenterol Hepatol 2018;30:1148-54. [PMID: 30095479 DOI: 10.1097/MEG.0000000000001208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
37 Bateman ME, Strong AL, Gimble JM, Bunnell BA. Concise Review: Using Fat to Fight Disease: A Systematic Review of Nonhomologous Adipose-Derived Stromal/Stem Cell Therapies. Stem Cells 2018;36:1311-28. [PMID: 29761573 DOI: 10.1002/stem.2847] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 21.7] [Reference Citation Analysis]
38 Pan J, Lee Y, Lee HH, Sung T, Jen SH, Ban L, Su H, Chen D, Hsu S, Higuchi A, Chen H. Culture and differentiation of purified human adipose-derived stem cells by membrane filtration via nylon mesh filters. J Mater Chem B 2020;8:5204-14. [DOI: 10.1039/d0tb00947d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Neurath MF. Current and emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol. 2017;14:269-278. [PMID: 28144028 DOI: 10.1038/nrgastro.2016.208] [Cited by in Crossref: 214] [Cited by in F6Publishing: 209] [Article Influence: 53.5] [Reference Citation Analysis]
40 Tavares MMR, Barbosa LER. Adipose tissue-derived stem cells: a new approach to the treatment of Crohn's disease-associated perianal fistulae. Journal of Coloproctology 2021;38:240-5. [DOI: 10.1016/j.jcol.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kagia A, Tzetis M, Kanavakis E, Perrea D, Sfougataki I, Mertzanian A, Varela I, Dimopoulou A, Karagiannidou A, Goussetis E. Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease. Inflammation 2019;42:1730-40. [PMID: 31227956 DOI: 10.1007/s10753-019-01033-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
42 Lansdorp CA, Buskens CJ, Gecse KB, D'Haens GRAM, van Hulst RA. Hyperbaric oxygen therapy for the treatment of rectovaginal fistulas in patients with Crohn's disease: results of the HOT-REVA pilot study. BJS Open 2021;5:zrab042. [PMID: 34046674 DOI: 10.1093/bjsopen/zrab042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC, Scharl M. Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:995-1009. [PMID: 32160284 DOI: 10.1093/ecco-jcc/jjaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
44 Lohsiriwat V, Jitmungngan R. Rectovaginal fistula after low anterior resection: Prevention and management. World J Gastrointest Surg 2021; 13(8): 764-771 [PMID: 34512900 DOI: 10.4240/wjgs.v13.i8.764] [Reference Citation Analysis]
45 Marlicz W, Łoniewski I, Skonieczna-Żydecka K. Stem and Progenitor Cells in the Pathogenesis and Treatment of Digestive Diseases. Adv Exp Med Biol 2019;1201:125-57. [PMID: 31898785 DOI: 10.1007/978-3-030-31206-0_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Silva Couto P, Rotondi M, Bersenev A, Hewitt C, Nienow A, Verter F, Rafiq Q. Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds. Biotechnology Advances 2020;45:107636. [DOI: 10.1016/j.biotechadv.2020.107636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
47 Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, Terai S. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regen. 2017;37:16. [PMID: 29259715 DOI: 10.1186/s41232-017-0045-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
48 Trébol J, Georgiev-Hristov T, Vega-Clemente L, García-Gómez I, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Rat model of anal sphincter injury and two approaches for stem cell administration. World J Stem Cells 2018; 10(1): 1-14 [PMID: 29391927 DOI: 10.4252/wjsc.v10.i1.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Al-Ghadban S, Bunnell BA. Adipose Tissue-Derived Stem Cells: Immunomodulatory Effects and Therapeutic Potential. Physiology (Bethesda) 2020;35:125-33. [PMID: 32027561 DOI: 10.1152/physiol.00021.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
50 Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3:249-260. [PMID: 31276044 DOI: 10.1002/jgh3.12141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
51 Cassinotti A, Passamonti F, Segato S. CELL THERAPY IN INFLAMMATORY BOWEL DISEASE. Pharmacol Res 2021;163:105247. [PMID: 33069755 DOI: 10.1016/j.phrs.2020.105247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Hawkey CJ, Hommes DW. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases? Gastroenterology 2017;152:389-397.e2. [PMID: 27845055 DOI: 10.1053/j.gastro.2016.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
53 Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V. Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature. Stem Cells Cloning 2018;11:95-113. [PMID: 30568468 DOI: 10.2147/SCCAA.S135414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Mazini L, Rochette L, Amine M, Malka G. Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int J Mol Sci. 2019;20:2523. [PMID: 31121953 DOI: 10.3390/ijms20102523] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 43.0] [Reference Citation Analysis]
55 Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci 2017;62:851-60. [PMID: 28168575 DOI: 10.1007/s10620-017-4453-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]